Skip to main content

Table 1 Effects of baseline clinical and investigational parameters on classes of lupus nephrits

From: Outcome of low dose cyclophosphamide for induction phase treatment of lupus nephritis, a single center study

Parameter

Class IV

Other classes

P value

 

(n = 22)

(n = 19)

 

Mean age in years

26.2 (±8.7)

28.7 (±11.5)

0.42

Mean duration of symptoms in days

152.5

785.5

0.02

 

(±304.5)

(±1206.2)

 

Number of patients with SBP (in mmHg)

 ≥140

9 (40.9 %)

5 (26.3 %)

0.33

 <140

13 (59.1 %)

14 (73.7 %)

 

Mean leukocyte count/mm3

5702

5912

0.82

 

(±2345)

(±3505)

 

Mean platelet count/mm3

145,395

206,805

0.09

 

(±66092)

(±150947)

 

Mean hemoglobin in g%

9.2 (±2.3)

9.1 (±2.4)

0.88

Mean eGFR in ml/min

54.5 (±28)

62.9 (±42.4)

0.45

Number of patients with eGFR

 ≥60 ml/min

10 (45.4 %)

8(42.1 %)

0.83

 <60 ml/min

12 (54.6 %)

11(57.9 %)

 

Mean serum albumin in g/L

21.5 (±5.6)

21.2 (±7.1)

0.88

Mean UTP in mg/day

3903.2

2533.1

0.05

 

(±2767.6)

(±126.8)

 
  1. SBP systolic blood pressure, eGFR estimated glomerular filtration rate, UTP urinary total protein, (±) standard deviation